Lub Clovis Oncology Inc (Nasdaq: CLVS) muaj yeem pib Tshooj 11 tab tom ua nyob rau hauv US Bankruptcy Court thiab yuav nrhiav kev muag nws cov cuab tam los ntawm lub tsev hais plaub-saib xyuas kev muag khoom.
Cov nuj nqis tau ua ntau yam "thawj hnub" tsab ntawv tsa suab nrog Lub Tsev Hais Plaub Ntug Nyiaj Txiag thov kom muaj kev pab cuam raws li txoj cai uas yuav ua rau lawv hloov mus rau Tshooj 11 yam tsis muaj kev cuam tshuam cov khoom siv rau lawv cov kev ua haujlwm ib txwm ua.
Related: Clovis Oncology Shares Nose-Dive as Potential Bankruptcy Filing Looms.
Clovis tau txais kev cog lus txog li $ 75 lab nyob rau hauv ib qho chaw qiv nyiaj ntau tus neeg muaj nuj nqis (DIP) nyiaj txiag.
Ua ntej Tshooj 11 ua ntaub ntawv, thiab raug tso cai rau Tsev Hais Plaub Ntug Txhaum Cai, Clovis tau nkag mus rau hauv "tus nees stalking" yuav thiab daim ntawv cog lus nrog Novartis Innovative Therapies AG rau FAP-2286 rau kev them nyiaj ua ntej ntawm $ 50 lab thiab mus txog $ 333.75 lab ntxiv raws li kev txhim kho & kev tswj hwm qhov tseem ceeb thiab $ 297 lab nyob rau tom qab kev muag khoom tseem ceeb.
Clovis tseem koom nrog kev sib tham nrog ntau tus neeg txaus siab rau kev muag khoom ntawm ib lossis ntau dua ntawm nws cov khoom muaj nqis.
Nqe Nqis: CLVS shares tau nqis 11.50% ntawm $ 0.18 thaum lub sijhawm ua ntej kev lag luam ntawm daim tshev kawg hnub Monday.
Saib ntxiv ntawm Benzinga
Tsis txhob nco lub sijhawm ceeb toom ntawm koj cov khoom lag luam - koom Lub Npe Lub Npe Pro dawb! Sim cov cuab yeej uas yuav pab koj nqis peev smarter, sai dua, thiab zoo dua.
© 2022 Benzinga.com. Benzinga tsis muab lus qhia txog peev. Qoob loo.
Tau qhov twg los: https://finance.yahoo.com/news/cancer-focused-clovis-oncology-files-122921375.html